Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy

被引:36
|
作者
von Gruenigen, Vivian E. [1 ]
Frasure, Heidi E. [2 ]
Kavanagh, Mary Beth [3 ]
Lerner, Edith [3 ]
Waggoner, Steven E. [2 ]
Courneya, Kerry S. [4 ]
机构
[1] Summa Hlth Syst Akron City Hosp, Akron, OH USA
[2] Univ Hosp, Case Med Ctr, Cleveland, OH USA
[3] Case Western Reserve Univ, Cleveland, OH 44106 USA
[4] Univ Alberta, Edmonton, AB, Canada
关键词
Ovarian cancer; Lifestyle; Nutrition; Physical activity; Quality of life; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; FUNCTIONAL ASSESSMENT; RANDOMIZED-TRIAL; FATIGUE; SURVIVAL; EXERCISE; ASSOCIATIONS; VALIDITY; EVENTS;
D O I
10.1016/j.ygyno.2011.04.043
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. This study aimed to assess the feasibility of a lifestyle intervention for promoting physical activity (PA) and diet quality during adjuvant chemotherapy for ovarian cancer. Methods. Patients were enrolled post-operatively and received PA and nutrition counseling, at every chemotherapy visit for six cycles. Quality of life (QoL) was measured with the Functional Assessment of Cancer Therapy (FACT-G), PA with the Leisure Score Index (LSI), dietary intake with 3-day food records, and symptom severity/distress by the Memorial Symptom Assessment Scale (MSAS). Pedometer step count was collected during chemotherapy cycles. Results. Recruitment was 73% with 27 patients enrolled. Mean [95% confidence interval] change in minutes of PA from cycle #3 to following cycle #6 was 61 min [-3, 120] p = 0.063, and from baseline to after cycle #6 was 73 min [-10, 15]; p = 0.082. Mean change in total fruit and vegetable consumption between baseline and during chemotherapy was 0.56 [-0.09, 0.64]; p = 0.090. FACT-G increased from 75.4 at baseline to 77.6 during chemotherapy and 83.9 following chemotherapy (p = 0.001 for change from baseline to post-chemotherapy). Mean total MSAS score was 20.6 at baseline, 26.6 at cycle #3 and decreased to 17.0 following chemotherapy (p = 0.01 comparison of cycle #3 and following chemotherapy). Increased moderate to strenuous PA was correlated with higher physical well-being during chemotherapy (r = 0.48, p = 0.037). Conclusions. Lifestyle counseling during adjuvant chemotherapy for ovarian cancer is feasible and may improve PA and diet quality. Randomized controlled trials examining the effects of lifestyle counseling on quality of life and treatment outcomes in ovarian cancer patients are warranted. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:328 / 333
页数:6
相关论文
共 50 条
  • [1] Experiences of Patients With Breast Cancer of Participating in a Lifestyle Intervention Study While Receiving Adjuvant Chemotherapy
    Vassbakk-Brovold, Karianne
    Antonsen, Anne J.
    Berntsen, Sveinung
    Kersten, Christian
    Fegran, Liv
    CANCER NURSING, 2018, 41 (03) : 218 - 225
  • [2] OVARIAN-FUNCTION IN PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
    ROSE, DP
    DAVIS, TE
    LANCET, 1977, 1 (8023): : 1174 - 1176
  • [3] Palliative Cancer Patients' Experiences of Participating in a Lifestyle Intervention Study While Receiving Chemotherapy
    Mikkelsen, Hilde Elisabeth Timenes
    Brovold, Karianne Vassbakk
    Berntsen, Sveinung
    Kersten, Christian
    Fegran, Liv
    CANCER NURSING, 2015, 38 (06) : E52 - E58
  • [4] SEDENTARY LIFESTYLE AND PHYSICAL ACTIVITY LEVELS IN PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY
    Tonosaki, A.
    Ishikawa, M.
    BREAST, 2013, 22 : S116 - S116
  • [5] Feasibility of adjuvant chemotherapy for breast cancer patients
    Imoto, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (05) : 310 - 315
  • [6] Feasibility of a Preventive Intervention for Insomnia in Women with Breast Cancer Receiving Chemotherapy
    Marion, Louis-Philippe
    Ivers, Hans
    Savard, Josee
    BEHAVIORAL SLEEP MEDICINE, 2021, 19 (01) : 70 - 82
  • [7] Patterns of fatigue in ovarian cancer patients receiving chemotherapy
    Basen-Engquist, K.
    De Moor, C.
    PSYCHO-ONCOLOGY, 2006, 15 (02) : S65 - S66
  • [8] Quality of life in ovarian cancer patients receiving chemotherapy
    Lakusta, CM
    Atkinson, MJ
    Robinson, JW
    Nation, J
    Taenzer, PA
    Campo, MG
    GYNECOLOGIC ONCOLOGY, 2001, 81 (03) : 490 - 495
  • [10] Characterization of neutropenic fever in patients receiving first-line adjuvant chemotherapy for epithelial ovarian cancer
    Sharma, Sameer
    Rezai, Katayoun
    Driscoll, Deborah
    Odunsi, Kunle
    Lele, Shashikant
    GYNECOLOGIC ONCOLOGY, 2006, 103 (01) : 181 - 185